Hurley, Thomas D., 1961-Ivanova, Yvelina TsvetanovaGoebl, Mark G.Srour, Edward F.2013-12-102013-12-102011-05-30https://hdl.handle.net/1805/3744http://dx.doi.org/10.7912/C2/1846Indiana University-Purdue University Indianapolis (IUPUI)Recent work has shown that specific ALDH isoenzymes can contribute to the underlying pathology of different diseases. Many ALDH isozymes are important in oxidizing reactive aldehydes resulting from lipid peroxidation, and, thus, help maintain cellular homeostasis. Increased expression and activity of ALDH isozymes are found in many human cancers and are often associated with poor prognosis. Therefore, the development of inhibitors of the different ALDH enzymes is of interest as means to treat some of these disease states. Here I describe the results of assays designed to characterize the site of interaction and the mode of inhibition for the unique compounds that function as inhibitors of aldehyde dehydrogenase 2 and determine their respective IC50 values with intent to develop structure-activity relationships for future development.en-USALDH2CharacterizationHigh-throughput docking approachAldehyde dehydrogenase -- InhibitorsIsoenzymesHomeostasisCancer cells -- Growth -- RegulationHigh throughput screening (Drug development) -- ResearchEnzyme inhibitors -- Structure-activity relationshipsEnzyme inhibitors -- Therapeutic use -- TestingPathology, Cellular -- ResearchThesis